Medicine & Life Sciences
Carcinoma, Intraductal, Noninfiltrating
100%
Clinical Trials, Phase I
59%
Vaccines
55%
Breast Neoplasms
28%
Immunization
18%
Immunity
18%
Tamoxifen
11%
Neoplasms
10%
Vaccination
8%
Estrogen Antagonists
8%
Health
8%
Incidence
8%
Breast Cancer 3
8%
Extranodal Extension
7%
Uterine Neoplasms
7%
Costs and Cost Analysis
6%
Aromatase Inhibitors
6%
Drug Therapy
6%
Safety
6%
Segmental Mastectomy
6%
Oncogene Proteins
6%
Mastectomy
6%
Risk Management
6%
Preliminary Data
6%
Research Ethics Committees
5%
Endometrial Neoplasms
5%
United States Food and Drug Administration
5%
Standard of Care
5%
Estrogen Receptors
5%
Uterine Cervical Neoplasms
5%
Weight Gain
5%